Clinical trials
Descemet Membrane Endothelial Keratoplasty (DMEK) clinical trials
Below are recruiting descemet membrane endothelial keratoplasty (dmek) clinical trials, each written for real people, not researchers. We’re tracking 5 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05072262RecruitingPhase 4
Topical anti-inflammatory eye drops after corneal transplant
This study tests whether anti-inflammatory eye drops (nepafenac, an NSAID) can help reduce swelling in the macula (the sharp-vision part of the eye) after certain cornea transplant surgeries. It compares outcomes in adults having DSAEK or DMEK who can safely use the study drops.
OsloAges 18 years+ - NCT06013462Recruiting
Corneal transplant after earlier eye surgery
This trial tests a type of corneal transplant (DMEK) in people who have had previous eye surgeries, such as vitrectomy or glaucoma surgery. It aims to see if the transplant works well even in these complicated cases.
ParisAges 18 years+ - NCT06425666Recruiting
Cataract surgery with triple-DMEK for Fuchs dystrophy
This trial tests a combined surgery that treats both cataract and Fuchs endothelial corneal dystrophy at the same time. It compares the standard cataract surgery to one that also replaces the damaged cornea layer, aiming to improve vision with fewer steps.
Aarhus N, Central JutlandAges 18 years+ - NCT07373821Recruiting
Lying face up after cornea transplant surgery
This study tests if lying face up after DMEK surgery (a cornea transplant for Fuchs dystrophy) helps the surgery work better. It may be an option for people with Fuchs dystrophy or bullous keratopathy who can lie flat on their back.
HeidelbergAges Any age - NCT05847387Recruiting
Checking endothelial cell health before corneal transplant
This study tests how well a patient’s corneal lining cells are preserved before corneal transplantation, and uses that to guide the transplant approach. It may help improve transplant planning and outcomes for people who need treatment for conditions like keratoconus or Fuchs endothelial dystrophy.
EdegemAges 18 years+
Hear when a new Descemet Membrane Endothelial Keratoplasty (DMEK) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for descemet membrane endothelial keratoplasty (dmek)?
- Yes. Clin2 currently lists 5 recruiting descemet membrane endothelial keratoplasty (dmek) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a descemet membrane endothelial keratoplasty (dmek) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a descemet membrane endothelial keratoplasty (dmek) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.